GuidanceMolina Healthcare Inc. maintains a positive 2024 adjusted EPS guidance, expressing confidence in its longer-term outlook.
Market PerformanceMolina Healthcare Inc. highlights a substantial upcoming pipeline, including $60 billion RFPs and a strong Marketplace performance, supporting revenue and long-term EPS targets.
Stock RatingDespite adjustments, long-term earnings forecasts remain stable, and the stock trades at an attractive multiple compared to historical averages, leading to a Buy rating.